Global Varicella Vaccine Market Insights, Forecast to 2025

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
As for the global varicella vaccine industry, the industry structure is relatively concentrated. The 72.50% of market share in production is grasped by the top 5 manufacturers. The top three manufacturers are Merck, GSK and Shanghai Institute, which are close to 52 percent totally. The United States giant Merck, which has 30.40% market share in 2015, is the leader in the varicella vaccine industry. The manufacturers following Merck are GSK and Shanghai Institute, which respectively has 10.04% and 11.60% market share globally. The Shanghai Institute is the leader of China varicella vaccine industry.
The downstream industries of varicella vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of varicella vaccine will be obvious. In the foreseeable future, the varicella vaccine products will show an optimistic upward trend.
The growth rate in developed regions such as US and Europe is not very fast because they have higher product coverage. And the number of neonatal in their countries is decreasing. So the investors should pay more attention on developing countries such as south Asia, Latin America and Middle-east.
The global Varicella Vaccine market is valued at 3050 million US$ in 2018 and will reach 5550 million US$ by the end of 2025, growing at a CAGR of 7.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Varicella Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Varicella Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Varicella Vaccine in these regions.
This research report categorizes the global Varicella Vaccine market by top players/brands, region, type and end user. This report also studies the global Varicella Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

Market size by Product
Injection
Freeze-dried powder
Market size by End User
Kids Injection
Adults Injection

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Varicella Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Varicella Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Varicella Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Varicella Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Varicella Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Varicella Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions